EUVIMEDEUVIMED entdecken
Open Access

Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers

Cao Dai Phung, Trinh T T Tran, Brendon Zhi Jie Yeo, Rebecca Carissa Prajogo, Evelyn Saudjana, Eric Yew Meng Yeo, Chang Gao, Phuong H D Nguyen, Migara Kavishka Jayasinghe, Xuan T T Dang, Celest Phang Lixuan, Trinh Mai Nguyen und 10 weitere

Theranostics · 2025

DOI: 10.7150/thno.105519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Cao Dai Phung und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Tumor Microenvironment, Proto-Oncogene Proteins p21(ras), Extracellular Vesicles, DEAD Box Protein 58. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentProto-Oncogene Proteins p21(ras)Extracellular VesiclesDEAD Box Protein 58HumansAnimalsMiceCell Line, TumorCarcinoma, Non-Small-Cell LungColorectal NeoplasmsMutationPancreatic NeoplasmsLung NeoplasmsDendritic CellsReceptors, Immunologic

Stichwörter der Autor:innen

KRAS mutationRIG-I agonistantisense oligonucleotidescancer therapyextracellular vesicles

Substanzen

Proto-Oncogene Proteins p21(ras)DEAD Box Protein 58KRAS protein, humanRIGI protein, humanReceptors, Immunologic

Autor:innen und Institutionen

  • Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Vingroup Science and Technology Scholarship Program, Vin University, Hanoi, Vietnam.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
  • Institute of Structural Biology, Nanyang Technological University, Singapore.
  • Synthetic Biology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Cell Fate Engineering and Therapeutics Laboratory, A*STAR Institute of Molecular and Cell Biology, Singapore, 138673, Singapore.

Zitieren

APA

Phung, C. D., Tran, T. T. T., Yeo, B. Z. J., Prajogo, R. C., Saudjana, E., Yeo, E. Y. M., Gao, C., Nguyen, P. H. D., Jayasinghe, M. K., Dang, X. T. T., Lixuan, C. P., Nguyen, T. M., Peng, B., Le, A. H., Nguyen, T. T. T., Chan, G. M. E., Loh, Y. H., Goh, B. C., Tam, W. L., …, & Le, M. T. N. (2025). Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers. Theranostics. https://doi.org/10.7150/thno.105519

Vancouver

Phung CD, Tran TTT, Yeo BZJ, Prajogo RC, Saudjana E, Yeo EYM, et al. Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers. Theranostics. 2025. doi:10.7150/thno.105519

BibTeX
@article{Phung2025,
  author = {Phung, Cao Dai and Tran, Trinh T T and Yeo, Brendon Zhi Jie and Prajogo, Rebecca Carissa and Saudjana, Evelyn and Yeo, Eric Yew Meng and Gao, Chang and Nguyen, Phuong H D and Jayasinghe, Migara Kavishka and Dang, Xuan T T and Lixuan, Celest Phang and Nguyen, Trinh Mai and Peng, Boya and Le, Anh Hong and Nguyen, Tram T T and Chan, Gloria Mei En and Loh, Yuin-Han and Goh, Boon Cher and Tam, Wai Leong and Bonney, Glenn Kunnath and Luo, Dahai and Le, Minh T N},
  title = {Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.105519}
}
Kostenlos starten →